OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001157075

PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech, Inc. (CIK 0001157075, ticker PMCB, EIN 62-1772151) reported revenue of $0 for FY2026 (2025-05-01 to 2026-04-30) and net income of -$19.42 million (-$19,424,654) for FY2026 (2025-05-01 to 2026-04-30), as filed in its 10-K filed 2026-07-29 (accession 0001683168-26-005836).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends April 30).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001157075
TickersPMCB (Nasdaq)
EIN62-1772151
SIC industry code2836 Biological Products, (No Diagnostic Substances)
State or country of incorporationNV
Fiscal year endApril 30
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_0d3qd54m1sr0t16bfb0g1xhn1q
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$0FY20262025-05-01 to 2026-04-3010-K2026-07-290001683168-26-005836Revenues
Net income-$19,424,654FY20262025-05-01 to 2026-04-3010-K2026-07-290001683168-26-005836NetIncomeLoss
Total assets$46,753,242FY2026as of 2026-04-3010-K2026-07-290001683168-26-005836Assets
Total liabilities$11,772,424FY2026as of 2026-04-3010-K2026-07-290001683168-26-005836Liabilities
Stockholders' equity$33,294,926FY2026as of 2026-04-3010-K2026-07-290001683168-26-005836StockholdersEquity
Operating cash flow-$5,152,914FY20262025-05-01 to 2026-04-3010-K2026-07-290001683168-26-005836NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$2.77 per shareFY20262025-05-01 to 2026-04-3010-K2026-07-290001683168-26-005836EarningsPerShareDiluted
Shares outstanding10,735,649 sharesFY2026as of 2026-07-2410-K2026-07-290001683168-26-005836EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2017-2026, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20262025-05-01 to 2026-04-30$010-K2026-07-290001683168-26-005836
RevenueFY20252024-05-01 to 2025-04-30$010-K2026-07-290001683168-26-005836
RevenueFY20242023-05-01 to 2024-04-30$010-K2025-08-110001683168-25-005821
RevenueFY20232022-05-01 to 2023-04-30$010-K2024-08-130001683168-24-005575
RevenueFY20222021-05-01 to 2022-04-30$010-K2023-07-310001683168-23-005175
RevenueFY20212020-05-01 to 2021-04-30$010-K2022-07-280001683168-22-005189
RevenueFY20202019-05-01 to 2020-04-30$010-K2021-08-100001683168-21-003377
RevenueFY20192018-05-01 to 2019-04-30$010-K2020-08-130001683168-20-002680
RevenueFY20182017-05-01 to 2018-04-30$010-K2019-08-130001683168-19-002559
RevenueFY20172016-05-01 to 2017-04-30$010-K2018-07-200001683168-18-001994
Net incomeFY20262025-05-01 to 2026-04-30-$19,424,65410-K2026-07-290001683168-26-005836
Net incomeFY20252024-05-01 to 2025-04-30$30,656,05010-K2026-07-290001683168-26-005836
Net incomeFY20242023-05-01 to 2024-04-30$333,76310-K2025-08-110001683168-25-005821
Net incomeFY20232022-05-01 to 2023-04-30-$4,315,99310-K2024-08-130001683168-24-005575
Net incomeFY20222021-05-01 to 2022-04-30-$4,239,16110-K2023-07-310001683168-23-005175
Net incomeFY20212020-05-01 to 2021-04-30-$3,551,23610-K2022-07-280001683168-22-005189
Net incomeFY20202019-05-01 to 2020-04-30-$3,826,88810-K2021-08-100001683168-21-003377
Net incomeFY20192018-05-01 to 2019-04-30-$4,067,22810-K2020-08-130001683168-20-002680
Net incomeFY20182017-05-01 to 2018-04-30-$6,828,84110-K2019-08-130001683168-19-002559
Net incomeFY20172016-05-01 to 2017-04-30-$4,443,68510-K2018-07-200001683168-18-001994

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-09-142026-07-310001683168-26-007106pharmacyte_i10q-073126.htm
10-K2026-07-292026-04-300001683168-26-005836pharmacyte_i10k-043026.htm
10-Q2026-03-172026-01-310001683168-26-001917pharmacyte_i10q-013126.htm
10-Q2025-12-182025-10-310001683168-25-009259pharmacyte_i10q-103125.htm
10-Q2025-09-152025-07-310001683168-25-006991pharmacyte_i10q-073125.htm
10-K2025-08-112025-04-300001683168-25-005821pharmacyte_i10k-043025.htm
10-Q2025-03-172025-01-310001683168-25-001669pharmacyte_i10q-013125.htm
10-Q2024-12-132024-10-310001683168-24-008709pharmacyte_i10q-103124.htm
10-Q2024-09-172024-07-310001683168-24-006441pharmacyte_i10q-073124.htm
10-K2024-08-132024-04-300001683168-24-005575pharmacyte_i10k-043024.htm
10-Q2024-03-182024-01-310001683168-24-001525pharmacyte_i10q-013124.htm
10-Q2023-12-152023-10-310001683168-23-008889pharmacyte_i10q-103123.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001157075published by the sourcedata.sec.gov/submissions/CIK0001157075.json2026-10-21
Employer Identification Number (EIN) · US-EIN62-1772151published by the sourceaskebsa.dol.gov/FOIA%20Files/2024/Latest/F_5500_SF_2024_Latest.zip2026-10-22
Employer Identification Number (EIN) · US-EIN62-1772151published by the sourcedata.sec.gov/submissions/CIK0001157075.json2026-10-21

Same entity in other Olympus APIs

Records other Olympus APIs serve for this entity, linked through a published identifier (never matched on name).

APIRecordAPI pathLinked through
US Employee Benefits & Form 5500 APIsponsor/v1/form-5500/sponsors/621772151US-EIN 621772151

Former names

NameFromTo
NUVILEX, INC.2009-03-262015-01-09
EFOODSAFETY COM INC2001-08-202009-03-17

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001157075.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001157075.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001157075" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001157075/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001157075/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1157075"}

On SEC EDGAR

About this data